ILC Therapeutics is a startup based in the United Kingdom.
ILC Therapeutics is a company headquartered in the United Kingdom.
ILC Therapeutics is a UK-based cytokine engineering company that designs and develops engineered "hybrid interferons", a novel class of cytokine therapeutics intended to reduce toxicity and improve efficacy with an initial focus on infectious disease. The company operates a platform for rational design and selection of candidates and seeks co-development and licensing partners for clinical-stage assets.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.